Table 4 The effect of comorbidity on standard CVD screening
From: Cardiovascular screening in rheumatoid arthritis: a cross-sectional primary care database study
| Â | Number of patients (n (%)) | Unadjusted (OR (95% CI)) | Age and gender adjusted (OR (95% CI)) |
|---|---|---|---|
No RA or DM | 1071 (67.0) | 1.00 | 1.00 |
RA only | 353 (22.1) | 0.96 (0.74, 1.26) | 0.96 (0.72, 1.24) |
DM only | 127 (7.9) | 12.15 (7.53, 19.61) | 11.14 (6.86, 18.11) |
RA +DM | 48 (3.0) | 14.91 (6.62, 33.61) | 15.32 (6.70, 35.02) |
No RA or HTN | 651 (40.7) | 1.00 | 1.00 |
RA only | 192 (12.0) | 1.11 (0.74, 1.68) | 1.16 (0.77, 1.76) |
HTN only | 547 (34.2) | 5.34 (4.11, 6.94) | 4.82 (3.67, 6.35) |
RA +HTN | 209 (13.1) | 4.36 (3.11, 6.11) | 3.82 (2.70, 5.42) |
No RA or HLP | 800 (50.0) | 1.00 | 1.00 |
RA only | 267 (16.7) | 1.09 (0.76, 1.58) | 1.07 (0.68, 1.66) |
HLP only | 398 (24.9) | 12.31 (9.25, 16.38) | 9.78 (6.98, 12.87) |
RA +HLP | 134 (8.4) | 11.50 (7.62, 17.35) | 8.15 (5.40, 12.31) |